Skip to content
10-Q

Quarterly Report

CORNERSTONE THERAPEUTICS INC

0001193125-13-431855

← back to feed
Filed
Nov 7, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Oct 31, 2013 26.9M sh
Shares Diluted Q3 2013 · Sep 30, 2013 31.5M sh
Shares Diluted Q3 2013 · Sep 30, 2013 31.27M sh
Shares Diluted Q3 2013 · Sep 30, 2012 26.6M sh
Shares Diluted Q3 2013 · Sep 30, 2012 26.04M sh
Capex Q3 2013 · Sep 30, 2013 $844K
Capex Q3 2013 · Sep 30, 2012 $265K
Operating Cash Flow Q3 2013 · Sep 30, 2013 $28.4M
Operating Cash Flow restated Q3 2013 · Sep 30, 2012 −$4.79M
Long Term Debt Q3 2013 · Sep 30, 2013 $89.62M
Long Term Debt Q3 2013 · Dec 31, 2012 $89.54M
Cash And Equivalents Q3 2013 · Sep 30, 2013 $69.61M
Cash And Equivalents Q3 2013 · Dec 31, 2012 $56.25M
Cash And Equivalents Q3 2013 · Sep 30, 2012 $34.18M
Cash And Equivalents Q3 2013 · Dec 31, 2011 $73.97M
Stockholders Equity Q3 2013 · Sep 30, 2013 $186.71M
Stockholders Equity Q3 2013 · Dec 31, 2012 $166.17M
Current Liabilities Q3 2013 · Sep 30, 2013 $69.22M
Current Liabilities Q3 2013 · Dec 31, 2012 $66.83M
Total Liabilities Q3 2013 · Sep 30, 2013 $203.35M
Total Liabilities Q3 2013 · Dec 31, 2012 $203.2M
Current Assets Q3 2013 · Sep 30, 2013 $126.09M
Current Assets Q3 2013 · Dec 31, 2012 $102.57M
Total Assets Q3 2013 · Sep 30, 2013 $390.07M
Total Assets Q3 2013 · Dec 31, 2012 $369.38M
Eps Diluted Q3 2013 · Sep 30, 2013 $0.31
Eps Diluted Q3 2013 · Sep 30, 2013 $0.60
Eps Diluted Q3 2013 · Sep 30, 2012 $0.05
Eps Diluted Q3 2013 · Sep 30, 2012 −$0.19
Eps Basic Q3 2013 · Sep 30, 2013 $0.36
Eps Basic Q3 2013 · Sep 30, 2013 $0.67
Eps Basic Q3 2013 · Sep 30, 2012 $0.05
Eps Basic Q3 2013 · Sep 30, 2012 −$0.19
Sga Expense Q3 2013 · Sep 30, 2013 $16.37M
Sga Expense Q3 2013 · Sep 30, 2013 $43.29M
Sga Expense Q3 2013 · Sep 30, 2012 $12.93M
Sga Expense Q3 2013 · Sep 30, 2012 $32.75M
Rd Expense Q3 2013 · Sep 30, 2013 $594K
Rd Expense Q3 2013 · Sep 30, 2013 $2.04M
Rd Expense Q3 2013 · Sep 30, 2012 $2M
Rd Expense Q3 2013 · Sep 30, 2012 $3.73M
Net Income Q3 2013 · Sep 30, 2013 $9.58M
Net Income Q3 2013 · Sep 30, 2013 $17.76M
Net Income Q3 2013 · Sep 30, 2012 $1.25M
Net Income Q3 2013 · Sep 30, 2012 −$4.93M
Operating Income Q3 2013 · Sep 30, 2013 $16.04M
Operating Income Q3 2013 · Sep 30, 2013 $31.42M
Operating Income Q3 2013 · Sep 30, 2012 $2.72M
Operating Income Q3 2013 · Sep 30, 2012 −$5.95M
Cost Of Revenue Q3 2013 · Sep 30, 2013 $12.64M
Cost Of Revenue Q3 2013 · Sep 30, 2013 $34.9M
Cost Of Revenue Q3 2013 · Sep 30, 2012 $14.4M
Cost Of Revenue Q3 2013 · Sep 30, 2012 $31.98M
Revenue Q3 2013 · Sep 30, 2013 $53.7M
Revenue Q3 2013 · Sep 30, 2013 $132.08M
Revenue Q3 2013 · Sep 30, 2012 $37.53M
Revenue Q3 2013 · Sep 30, 2012 $81.16M